Published in J Clin Endocrinol Metab on June 01, 1997
Polychlorinated biphenyls disturb differentiation of normal human neural progenitor cells: clue for involvement of thyroid hormone receptors. Environ Health Perspect (2005) 1.04
Transcriptional regulation of the human glycoprotein hormone common alpha subunit gene by cAMP-response-element-binding protein (CREB)-binding protein (CBP)/p300 and p53. Biochem J (2002) 0.78
Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet (2001) 7.92
Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med (1998) 5.86
Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet (2001) 4.14
Long-term thyroxine treatment and bone mineral density. Lancet (1992) 3.67
Serum thyrotropin concentration as a novel predictor of malignancy in thyroid nodules investigated by fine-needle aspiration. J Clin Endocrinol Metab (2006) 3.49
Traumatic diaphragmatic hernia. Occult marker of serious injury. Ann Surg (1993) 3.28
Cost effectiveness of HMG-CoA reductase inhibitor (statin) treatment related to the risk of coronary heart disease and cost of drug treatment. Heart (1999) 2.69
Defining the normal cortisol response to the short Synacthen test: implications for the investigation of hypothalamic-pituitary disorders. Clin Endocrinol (Oxf) (1998) 2.59
Prevalence and follow-up of abnormal thyrotrophin (TSH) concentrations in the elderly in the United Kingdom. Clin Endocrinol (Oxf) (1991) 2.48
Expression of pituitary-tumour transforming gene in colorectal tumours. Lancet (2000) 2.39
Neonatal screening for inborn errors of metabolism: cost, yield and outcome. Health Technol Assess (1997) 2.20
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med (2000) 2.16
Helical CT technique for the diagnosis of appendicitis: prospective evaluation of a focused appendix CT examination. Radiology (1997) 2.16
Thyroxine replacement therapy and circulating lipid concentrations. Clin Endocrinol (Oxf) (1993) 2.00
Helical CT combined with contrast material administered only through the colon for imaging of suspected appendicitis. AJR Am J Roentgenol (1997) 1.98
Linkage disequilibrium between the human leukocyte antigen class II region of the major histocompatibility complex and Graves' disease: replication using a population case control and family-based study. J Clin Endocrinol Metab (1998) 1.72
Thyroxine prescription in the community: serum thyroid stimulating hormone level assays as an indicator of undertreatment or overtreatment. Br J Gen Pract (1993) 1.57
Long-term follow-up of treatment of thyrotoxicosis by three different methods. Clin Endocrinol (Oxf) (1991) 1.57
Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med (2007) 1.56
Sodium iodide symporter: a novel strategy to target breast, prostate, and other cancers? Lancet (2003) 1.56
Consensus statement: medical management of acromegaly. Eur J Endocrinol (2005) 1.54
Ultrasonography by emergency physicians in patients with suspected cholecystitis. Am J Emerg Med (2001) 1.50
Thyroid hormone receptor expression in the "sick euthyroid" syndrome. Lancet (1990) 1.46
An audit of management of differentiated thyroid cancer in specialist and non-specialist clinic settings. Clin Endocrinol (Oxf) (2001) 1.46
Radioiodine treatment of hyperthyroidism-prognostic factors for outcome. J Clin Endocrinol Metab (2001) 1.45
Clinical, quality of life, and economic value of acromegaly disease control. Pituitary (2011) 1.44
Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype. J Clin Endocrinol Metab (2006) 1.37
Thyroid hormone in health and disease. J Endocrinol (2005) 1.35
Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. II. Children with disability. Arch Dis Child Fetal Neonatal Ed (1996) 1.31
Upper airways obstruction in 153 consecutive patients presenting with thyroid enlargement. BMJ (1996) 1.31
Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med (1998) 1.28
Giant invasive prolactinoma: a case report and review of nine further cases. Q J Med (1990) 1.28
Contribution of single nucleotide polymorphisms within FCRL3 and MAP3K7IP2 to the pathogenesis of Graves' disease. J Clin Endocrinol Metab (2005) 1.27
Pituitary tumor transforming gene and fibroblast growth factor-2 expression: potential prognostic indicators in differentiated thyroid cancer. J Clin Endocrinol Metab (2003) 1.24
Age and gender predict the outcome of treatment for Graves' hyperthyroidism. J Clin Endocrinol Metab (2000) 1.22
Lack of association between serum TSH or free T4 and body mass index in euthyroid subjects. Clin Endocrinol (Oxf) (2006) 1.21
Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. J Clin Endocrinol Metab (2004) 1.18
Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab (2002) 1.16
Thyroxine replacement treatment and osteoporosis. BMJ (1990) 1.14
Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism. QJM (1995) 1.14
Cost of care for a geographically determined population of low birthweight infants to age 8-9 years. I. Children without disability. Arch Dis Child Fetal Neonatal Ed (1996) 1.13
The renal expression of transforming growth factor-beta isoforms and their receptors in acute and chronic experimental diabetes in rats. Endocrinology (2000) 1.11
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation. J Bone Miner Res (2001) 1.11
Placental iodothyronine deiodinase expression in normal and growth-restricted human pregnancies. J Clin Endocrinol Metab (2003) 1.09
Delayed appendectomy for appendicitis: causes and consequences. Am J Emerg Med (1996) 1.08
Stump appendicitis diagnosed preoperatively by computed tomography. Am J Emerg Med (1998) 1.08
Ultrasonography by emergency physicians in patients with suspected ureteral colic. J Emerg Med (1999) 1.08
Weight gain following treatment of hyperthyroidism. Clin Endocrinol (Oxf) (2001) 1.07
Securin induces genetic instability in colorectal cancer by inhibiting double-stranded DNA repair activity. Carcinogenesis (2006) 1.06
Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon. QJM (1999) 1.05
Vascular complications of intra-aortic balloon counterpulsation. Arch Surg (1983) 1.03
Expression of pituitary tumour transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in human pituitary adenomas: relationships to clinical tumour behaviour. Clin Endocrinol (Oxf) (2003) 1.03
The in vitro effects of triiodothyronine on epidermal growth factor-induced trophoblast function. J Clin Endocrinol Metab (2004) 1.03
Differential expression of oestrogen receptor and oestrogen inducible genes in gastric mucosa and cancer. Gut (1997) 1.02
Licorice inhibits 11 beta-hydroxysteroid dehydrogenase messenger ribonucleic acid levels and potentiates glucocorticoid hormone action. Endocrinology (1993) 1.02
The development of Graves' disease and the CTLA-4 gene on chromosome 2q33. J Clin Endocrinol Metab (1999) 1.01
Differential growth response to oestrogen of premalignant and malignant colonic cell lines. Anticancer Res (1994) 1.01
Hypertension in the syndrome of apparent mineralocorticoid excess due to mutation of the 11 beta-hydroxysteroid dehydrogenase type 2 gene. Lancet (1996) 1.01
ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab (2009) 1.01
Propylthiouracil and carbimazole associated-antineutrophil cytoplasmic antibodies (ANCA) in patients with Graves' disease. Clin Endocrinol (Oxf) (2004) 1.01
Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab (1999) 1.00
Fine needle aspiration cytology in diffuse or multinodular goitre compared with solitary thyroid nodules. BMJ (1993) 1.00
Abnormal expression of 11 beta-hydroxysteroid dehydrogenase type 2 in human pituitary adenomas: a prereceptor determinant of pituitary cell proliferation. Oncogene (2003) 0.99
Tag SNP screening of the PDCD1 gene for association with Graves' disease. Clin Endocrinol (Oxf) (2007) 0.98
Circulating thyroid hormone concentrations and placental thyroid hormone receptor expression in normal human pregnancy and pregnancy complicated by intrauterine growth restriction (IUGR). J Clin Endocrinol Metab (1998) 0.98
A genome-wide screen in 1119 relative pairs with autoimmune thyroid disease. J Clin Endocrinol Metab (2005) 0.98
Sex differences in the incidence of colorectal cancer: an exploration of oestrogen and progesterone receptors. Gut (1993) 0.98
Cardiac hypertrophy as a result of long-term thyroxine therapy and thyrotoxicosis. Heart (1996) 0.97
MHC class II region, CTLA4 gene, and ophthalmopathy in patients with Graves' disease. Lancet (2001) 0.97
Long-term therapy with long-acting octreotide (Sandostatin-LAR) for the management of acromegaly. Clin Endocrinol (Oxf) (1998) 0.97
Older subjects with hyperthyroidism present with a paucity of symptoms and signs: a large cross-sectional study. J Clin Endocrinol Metab (2010) 0.97
Association of a rare thyroglobulin gene microsatellite variant with autoimmune thyroid disease. J Clin Endocrinol Metab (2003) 0.97
Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74. Clin Endocrinol (Oxf) (2006) 0.97
Monocarboxylate transporter 8 expression in the human placenta: the effects of severe intrauterine growth restriction. J Endocrinol (2006) 0.96
Thyrotoxicosis with heart block. J R Soc Med (2001) 0.96